The cardiovascular drug manufacturing industry is essential for developing medications aimed at treating heart and vascular diseases, which affect millions globally. This industry includes a mix of established pharmaceutical companies and innovative startups, all working to create specialized treatments tailored to patients' needs. They offer a wide range of products, from traditional pharmaceuticals to breakthrough therapies targeting complex cardiovascular conditions. As technology advances, companies increasingly adopt biopharmaceutical methods and personalized medicine, changing how cardiovascular diseases are treated and managed, with a focus on improving patient outcomes and enhancing drug efficacy.

The following companies represent a spectrum of the cardiovascular drug manufacturing sector, showcasing various sizes and origins. Ranging from family-owned enterprises to corporate giants, they have roots in countries like Hungary, Italy, and India. Founded between 1913 and 2018, each company specializes in cardiology, highlighting their dedication to developing effective cardiovascular treatments. With a workforce that varies widely, these firms collectively address critical health challenges in the cardiovascular arena.

Continue reading to discover the top cardiovascular drug manufacturing companies.

Top 26 Cardiovascular Drug Manufacturing Companies

1. Egis Pharmaceuticals PLC

• Website: egis.health
• Ownership type: Private
• Headquarters: Budapest, Budapest, Hungary
• Employee distribution: Hungary 81%, Russia 3%, Romania 3%, Other 14%
• Founded year: 1913
• Headcount: 1001-5000
• LinkedIn: egis-pharmaceuticals-plc

Egis Pharmaceuticals PLC, based in Budapest, Hungary, has been a significant player in the pharmaceutical industry since its founding in 1913. The company specializes in the development and manufacturing of medicines, with a particular emphasis on cardiovascular and central nervous system diseases. With a workforce of approximately 1,931 employees, Egis operates across various stages of the pharmaceutical value chain, including research and development, manufacturing of active ingredients, and finished product development. Their portfolio includes a wide range of prescription medications and over-the-counter solutions, catering to both healthcare professionals and consumers. Egis's commitment to innovation is evident in their substantial investment in R&D, which aims to enhance their product offerings and address the evolving needs of patients. Their products are distributed in over 100 countries, showcasing their international reach and impact in the pharmaceutical market.

2. Daiichi Sankyo Italia S.p.A.

• Website: daiichi-sankyo.it
• Ownership type: Family Owned
• Headquarters: Rome, Lazio, Italy
• Employee distribution: Italy 100%
• Founded year: 2006
• Headcount: 1001-5000
• LinkedIn: daiichi-sankyo-italia

Daiichi Sankyo Italia S.p.A., founded in 2006 and based in Rome, Lazio, is a family-owned pharmaceutical company. It specializes in the development and manufacturing of products primarily in the cardiovascular and oncology sectors. The company is dedicated to serving healthcare providers and patients, emphasizing innovative treatments that aim to enhance health outcomes. Daiichi Sankyo Italia is involved in extensive research and development activities, ensuring that their pharmaceutical preparations meet high-quality standards. Their operations are supported by modern production facilities that comply with international regulations, including those set by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This commitment to quality and innovation underlines their role in the cardiovascular drug market.

3. Daiichi Sankyo France

• Website: daiichi-sankyo.fr
• Ownership type: Private
• Headquarters: Poitou-Charentes, Nouvelle-Aquitaine, France
• Employee distribution: France 100%
• Founded year: 2002
• Headcount: 51-200
• LinkedIn: daiichi-sankyo-france

Daiichi Sankyo France SAS, founded in 2002, operates out of Poitou-Charentes, Nouvelle-Aquitaine, France. The company is a private entity with a workforce of approximately 170 employees. It specializes in the development and manufacturing of therapeutic products, particularly in the fields of oncology and cardiology. Daiichi Sankyo France is committed to innovative research and development, aiming to provide effective treatments for serious health conditions. Their product offerings include a range of therapies for cardiovascular diseases, showcasing their involvement in this critical area of healthcare. The company adheres to high manufacturing standards, with production sites in France and Germany that comply with international regulations. This commitment to quality and innovation positions them as a notable player in the pharmaceutical industry.

4. Pinnacle Life Science Pvt. Ltd (Subsidiary of Aarti Drugs)

• Website: pinnaclelifescience.com
• Ownership type: Private
• Headquarters: Mumbai, Maharashtra, India
• Employee distribution: India 96%, Chile 2%, Other 2%
• Founded year: 2014
• Headcount: 1001-5000
• LinkedIn: pinnacle-lifescience-private-limited

Pinnacle Life Science Pvt. Ltd, a subsidiary of Aarti Drugs, was established in 2014 and is based in Mumbai, Maharashtra, India. The company specializes in the formulation and export of high-quality pharmaceuticals, focusing on various therapeutic areas, including oncology and cardiovascular health. With a workforce of around 295 employees, Pinnacle operates state-of-the-art manufacturing facilities that have received US FDA and multiple GMP approvals. Their commitment to innovation is evident in their extensive research and development efforts, which aim to create effective and safe medications. Pinnacle Life Science exports its products to over 90 countries, catering to healthcare providers and pharmaceutical companies that require reliable treatments. Their portfolio includes over 80 finished products, with a notable emphasis on cardiovascular medications, showcasing their active involvement in this critical area of healthcare.

5. Bial

• Website: bial.com
• Ownership type: Private
• Headquarters: Portugal
• Employee distribution: Portugal 59%, Spain 18%, Italy 4%, Other 18%
• Founded year: 1924
• Headcount: 501-1000
• LinkedIn: bial

Bial is a private pharmaceutical company based in Portugal, founded in 1924. With a workforce of approximately 938 employees, Bial is dedicated to discovering, developing, and commercializing medicines that aim to enhance health outcomes. The company has a strong emphasis on research and development, particularly in the fields of neurology and cardiology. Bial's product offerings include a range of pharmaceutical products that address various health issues, including cardiovascular diseases. Their commitment to innovation is evident in their active participation in clinical trials and their strategic expansion into new therapeutic modalities. Bial operates in multiple countries, including Portugal, Spain, Italy, Germany, and India, and has established a presence in over 50 countries worldwide. This international reach allows Bial to serve healthcare providers and patients effectively, contributing to their mission of improving lives through better health solutions.

6. Pharma Dynamics (Pty) Ltd

• Website: pharmadynamics.co.za
• Ownership type: Corporate
• Headquarters: Cape Town, Western Cape, South Africa
• Employee distribution: South Africa 98%, Philippines 2%
• Latest funding: March 2015
• Founded year: 2001
• Headcount: 51-200
• LinkedIn: pharma-dynamics-pty-ltd

Pharma Dynamics (Pty) Ltd, founded in 2001 and based in Cape Town, South Africa, is a pharmaceutical company that specializes in generic medications, with a strong emphasis on cardiovascular health. The company boasts a portfolio of 25 market-leading brands and has maintained its position as the largest supplier of cardiovascular pharmaceuticals in South Africa since 2011. With a workforce of approximately 175 employees, Pharma Dynamics is dedicated to improving healthcare access in South Africa and neighboring countries, including Namibia, Botswana, and Zambia. The company is a wholly owned subsidiary of Lupin Limited, a global pharmaceutical entity. In addition to its product offerings, Pharma Dynamics actively engages in community development and social responsibility initiatives, aiming to empower local communities through various educational and employment programs.

7. Biopharm

• Website: biopharmdz.com
• Ownership type: Private Equity
• Headquarters: Algiers [El Djazaïr], Algiers, Algeria
• Employee distribution: Algeria 98%, Other 2%
• Latest funding: September 2013
• Founded year: 1991
• Headcount: 1001-5000
• LinkedIn: pharmamedical

Biopharm, founded in 1991, is a private equity pharmaceutical company located in Algiers, Algeria. With a workforce of approximately 1,300 employees, Biopharm specializes in the manufacturing and distribution of a wide range of pharmaceutical products. The company serves healthcare providers, pharmacies, and patients, focusing on therapeutic areas such as rheumatology, oncology, and notably, cardiovascular health. Biopharm is dedicated to ensuring access to essential medications in Algeria and neighboring regions, emphasizing quality and compliance in their operations. They have established a significant presence in the Algerian pharmaceutical market, with multiple production facilities and a commitment to research and development. Their product offerings include medications for cardiovascular conditions, such as Irbesartan and Moxonidine, which are critical for managing hypertension and other cardiovascular issues. Biopharm's strategic investments and partnerships further enhance their capabilities in the pharmaceutical sector.

8. Daiichi Sankyo UK

• Website: daiichi-sankyo.co.uk
• Ownership type: Private
• Headquarters: Uxbridge, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Founded year: 2006
• Headcount: 201-500
• LinkedIn: daiichi-sankyo-uk-ltd

Daiichi Sankyo UK Ltd. is a pharmaceutical company based in Uxbridge, England, established in 2006. The company is part of a larger global organization with over 120 years of scientific expertise. Daiichi Sankyo UK focuses on innovative healthcare solutions, particularly in cardiology and oncology. Their commitment to cardiology is evident through their extensive portfolio of medicines designed to enhance patient care and improve quality of life. The company actively engages in research and development, conducting clinical trials to bring new therapies to market. They also collaborate with various NHS organizations to implement projects that directly benefit patient care, particularly in the management of cardiovascular diseases. This involvement underscores their role as a significant player in the cardiovascular drug manufacturing sector.

9. Gador

• Website: gador.com
• Ownership type: Private
• Headquarters: Argentina
• Employee distribution: Argentina 92%, Uruguay 2%, Other 6%
• Founded year: 1940
• Headcount: 1001-5000
• LinkedIn: gador

Gador S.A. is a private pharmaceutical company founded in 1940, headquartered in Buenos Aires, Argentina. With a workforce of approximately 1,184 employees, Gador is committed to producing high-quality medications that adhere to international standards. The company serves healthcare professionals, hospitals, and patients, focusing on improving access to essential treatments. Gador's product portfolio includes a range of therapeutic areas, with a notable section dedicated to cardiometabolism, indicating their involvement in cardiovascular health. They also engage in pharmacovigilance and clinical studies to ensure the safety and efficacy of their products. Gador operates primarily in Argentina, with a small presence in neighboring countries like Uruguay, and has a commitment to innovation and quality in the pharmaceutical sector.

10. EGIS Polska

• Website: egis.pl
• Ownership type: Private
• Headquarters: Warsaw, Masovian Voivodeship, Poland
• Employee distribution: Poland 100%
• Founded year: 1994
• Headcount: 201-500
• LinkedIn: egis-polska

EGIS Polska, founded in 1994 and based in Warsaw, Poland, is a private pharmaceutical company that specializes in the development and manufacturing of medicinal products. The company focuses on therapeutic areas such as cardiology and neurology, providing effective treatments for healthcare providers and patients. EGIS Polska is actively involved in research and development, dedicating substantial resources to innovate and enhance its product offerings. With a portfolio of 653 products available in 100 countries, EGIS Polska demonstrates a strong commitment to addressing health challenges, particularly in the cardiovascular domain. The company operates with a workforce of approximately 151 employees, all based in Poland, and emphasizes quality and compliance in its manufacturing processes.

11. Tecnimede Group

• Website: tecnimede.com
• Ownership type: Private
• Headquarters: Portugal
• Employee distribution: Portugal 72%, Morocco 15%, Spain 12%, Other 1%
• Founded year: 1980
• Headcount: 501-1000
• LinkedIn: tecnimede-group

Tecnimede Group, founded in 1980 and based in Portugal, is a private pharmaceutical company with a workforce of approximately 654 employees. The company specializes in the research, development, production, and distribution of pharmaceutical products. With a portfolio that includes over 130 products and more than 440 patents, Tecnimede is dedicated to treating prevalent illnesses, particularly in the fields of cardiovascular, metabolic, degenerative, and infectious diseases. Their global operations extend to over 100 countries, showcasing their commitment to addressing health challenges worldwide. Tecnimede's focus on cardiovascular disorders is a significant aspect of their business, reflecting their strategic priorities in the pharmaceutical sector.

12. Gruppo Servier in Italia

• Website: servier.it
• Ownership type: Private
• Headquarters: Rome, Lazio, Italy
• Employee distribution: Italy 100%
• Founded year: 1954
• Headcount: 201-500
• LinkedIn: gruppo-servier-in-italia

Gruppo Servier in Italia, founded in 1954, is a private pharmaceutical company based in Rome, Italy. It specializes in developing innovative medical treatments across various therapeutic areas, including oncology, cardiometabolism, and immuno-inflammation. The company has a strong commitment to research and development, investing over 20% of its revenue into this area, which is crucial for addressing unmet medical needs. In the cardiovascular sector, Servier has made notable strides, particularly with products aimed at managing hypertension and cholesterol levels. Their portfolio includes a polypill, the first of its kind authorized in Italy, designed to treat both hypertension and hypercholesterolemia simultaneously. This focus on cardiovascular health is complemented by their initiatives to improve patient adherence to therapies, which is vital in managing chronic conditions. Servier operates entirely within Italy, employing around 163 individuals and maintaining a robust presence in the pharmaceutical market.

13. Eddingpharm

• Website: eddingpharm.com
• Ownership type: Private Equity
• Headquarters: Jing'An, Shanghai, China
• Employee distribution: China 98%, Other 2%
• Latest funding: Series B, $24.0M, September 2010
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn: eddingpharm

Eddingpharm, established in 2001 and based in Shanghai, China, is a private equity-owned pharmaceutical company that specializes in the development and commercialization of innovative drugs. The company operates primarily in three therapeutic areas: anti-infectives, cardiovascular, and respiratory treatments. Eddingpharm has developed a comprehensive supply chain and manufacturing platform to ensure high-quality products for healthcare providers and patients. Notably, Eddingpharm has made significant strides in the cardiovascular sector, particularly with its product Vascepa®, which has received regulatory approval for reducing cardiovascular events in high-risk patients. The company has also been involved in various clinical trials and has a robust pipeline of products aimed at addressing unmet medical needs in cardiovascular health. With a workforce of over 1,000 employees, Eddingpharm is well-positioned to impact the pharmaceutical landscape in China and beyond.

14. Donovan Werke

• Website: donovanwerke.com
• Ownership type: Private
• Headquarters: Guatemala
• Employee distribution: Guatemala 94%, Honduras 6%
• Founded year: 1978
• Headcount: 201-500
• LinkedIn: donovan-werke

Corporación Donovan Werke Internacional, founded in 1978, is a private pharmaceutical manufacturer located in Guatemala. The company is dedicated to the production and commercialization of medications aimed at enhancing health and quality of life. With a workforce of approximately 350 employees, Donovan Werke focuses on various therapeutic areas, including cardiovascular, metabolic, and respiratory medications. They have developed and marketed over 200 pharmaceutical products, catering to the needs of healthcare professionals and patients alike. The company operates a modern manufacturing facility that adheres to international quality standards, ensuring the efficacy and safety of their products. Donovan Werke's commitment to research and development is evident in their continuous efforts to innovate and improve their offerings, particularly in the cardiovascular sector, where they provide solutions to address critical health challenges.

15. Schazoo Zaka Pvt. (Ltd.)

• Website: schazoozaka.com
• Ownership type: Private
• Headquarters: Sheikhupura, Punjab, Pakistan
• Employee distribution: Pakistan 100%
• Founded year: 1951
• Headcount: 201-500
• LinkedIn: schazoo-zaka-ltd

Schazoo Zaka Pvt. (Ltd.) is a pharmaceutical company based in Sheikhupura, Punjab, Pakistan, established in 1951. Originally known as Schazoo Laboratories, the company has evolved to manufacture a wide array of healthcare products, prominently including cardiovascular drugs. Schazoo Zaka emphasizes high-quality production, adhering to international standards and regulations. Their operations are supported by a robust research and development team that focuses on creating innovative solutions to meet healthcare demands. The company is dedicated to maintaining strict quality control and assurance processes, which are integral to their manufacturing practices. With a workforce of 201-500 employees, Schazoo Zaka is committed to contributing positively to the healthcare landscape in Pakistan and beyond.

16. Tecnofarma Bolivia

• Website: tecnofarma.com.bo
• Ownership type: Private
• Headquarters: Santa Cruz De La Sierra, Santa Cruz, Bolivia
• Employee distribution: Bolivia 99%, Other 1%
• Founded year: 1988
• Headcount: 51-200
• LinkedIn: tecnofarma-bolivia

Tecnofarma Bolivia, established in 1988, is a private pharmaceutical company based in Santa Cruz De La Sierra, Bolivia. The company specializes in the development, manufacturing, and commercialization of healthcare products, with a strong emphasis on improving patient quality of life. Tecnofarma operates in various therapeutic areas, including cardiology, oncology, and immunology, and has built a significant portfolio of products aimed at addressing cardiovascular diseases. Their offerings include treatments for hypertension and hypercholesterolemia, which are critical in managing cardiovascular health. With a workforce of approximately 135 employees, Tecnofarma is dedicated to innovation and quality, ensuring that their products meet high standards. The company is part of the Adium Group, which enhances its capabilities and market presence across Latin America. Tecnofarma's commitment to research and development, along with their focus on effective treatments, positions them as a noteworthy player in the cardiovascular drug manufacturing sector.

17. AstraZeneca Italia

• Website: astrazeneca.it
• Ownership type: Private
• Headquarters: Basiglio, Lombardy, Italy
• Founded year: 1999
• Headcount: 501-1000
• LinkedIn: astrazeneca-italia

AstraZeneca Italia, established in 1999, operates from Basiglio, Lombardy, Italy. As a private pharmaceutical company, it specializes in the development and manufacturing of innovative medicines. AstraZeneca Italia is particularly focused on therapeutic areas such as oncology, respiratory diseases, and notably, cardiovascular and metabolic diseases. The company is dedicated to scientific research and adheres to high ethical standards, ensuring the delivery of quality products and services. AstraZeneca's commitment to addressing cardiovascular health is evident in their research and development efforts, which aim to provide effective solutions for healthcare providers and patients. With a workforce of around 1,000 employees, AstraZeneca Italia plays a significant role in the pharmaceutical industry, contributing to advancements in cardiovascular treatments.

18. Savant Pharm

• Website: savant.com.ar
• Ownership type: Private
• Headquarters: Argentina
• Employee distribution: Argentina 93%, Bolivia 7%
• Founded year: 1993
• Headcount: 201-500
• LinkedIn: savant-pharm-s-a-

Savant Pharm S.A. is a private pharmaceutical company based in Argentina, established in 1993. The company specializes in the development and commercialization of a wide array of medications across various therapeutic areas, including anti-infectives and cardiometabolic treatments. With a workforce of approximately 189 employees, Savant Pharm serves healthcare professionals and patients, providing essential medications to meet health needs. The company has a significant presence in Argentina, with a smaller footprint in Bolivia. Savant Pharm's product portfolio includes several cardiovascular medications, highlighting its commitment to addressing cardiometabolic health issues. The company operates an industrial complex in Córdoba, Argentina, which supports its manufacturing and distribution efforts.

19. Neopharmed Gentili S.P.A.

• Website: neogen.it
• Ownership type: Private
• Headquarters: Milan, Michigan, United States (USA)
• Employee distribution: Italy 100%
• Founded year: 2018
• Headcount: 201-500
• LinkedIn: neopharmed-gentili-s.p.a.

Neopharmed Gentili S.P.A. is a pharmaceutical company based in Milan, Italy, founded in 2018. The company specializes in the commercialization of high therapeutic value solutions, focusing on various therapeutic areas, including the cardio-metabolic and vascular sectors. Neopharmed Gentili aims to provide medications, medical devices, dietary supplements, and cosmetics to healthcare professionals and patients, with a mission to enhance health outcomes and quality of life. The company emphasizes innovation and research as core components of its operations, striving to develop effective treatments for chronic conditions that affect millions of patients annually. Their partnerships with multinational players like MSD and Teva further indicate their commitment to advancing therapeutic solutions in the cardiovascular domain. Neopharmed Gentili operates with a strong ethical framework and a focus on social responsibility, aiming to make a positive impact in the healthcare industry.

20. Servier Korea

• Website: servier.co.kr
• Ownership type: Private
• Headquarters: Seoul, Seoul, South Korea
• Employee distribution: South Korea 100%
• Founded year: 1990
• Headcount: 51-200
• LinkedIn: servier-korea-ltd

Servier Korea, established in 1990 and based in Seoul, South Korea, is a private pharmaceutical company dedicated to developing and manufacturing medications for various health conditions. The company places a strong emphasis on therapeutic advancements in cardiometabolism, oncology, immuno-inflammation, and neuroscience. In the cardiovascular sector, Servier Korea offers a range of products, including medications like Acertil and ProcoraIan, which are designed to address heart-related health issues. The company is committed to high-quality research and development, investing a significant portion of its revenue into creating effective solutions for healthcare professionals and patients. Servier Korea operates entirely within South Korea, ensuring that its products meet local healthcare needs and standards.

21. SERVIER Deutschland GmbH

• Website: servier.de
• Ownership type: Private
• Headquarters: Flensburg, Schleswig-Holstein, Germany
• Employee distribution: Germany 100%
• Founded year: 1996
• Headcount: 201-500
• LinkedIn: servier-deutschland

SERVIER Deutschland GmbH, founded in 1996 and based in Flensburg, Schleswig-Holstein, is a private pharmaceutical company dedicated to developing innovative therapies for a range of medical conditions. Their portfolio includes treatments for cardiovascular diseases, cancer, and depression, reflecting a broad commitment to addressing significant health challenges. The company emphasizes collaboration with healthcare providers to ensure effective treatment options are available to patients. With a workforce of approximately 103 employees, SERVIER Deutschland is part of a larger global organization that operates in over 150 countries. They invest significantly in research and development, allocating more than 20% of their pharmaceutical revenues to this area, particularly focusing on cardiovascular and metabolic diseases. This investment underscores their commitment to advancing medical science and improving patient outcomes.

22. Servier Polska

• Website: servier.pl
• Ownership type: Private
• Headquarters: Warsaw, Masovian Voivodeship, Poland
• Employee distribution: Poland 96%, Ukraine 4%
• Founded year: 1992
• Headcount: 501-1000
• LinkedIn: servierpolska

Servier Polska, established in 1992, is a private pharmaceutical company based in Warsaw, Poland. With a workforce of approximately 500 to 1000 employees, the company is dedicated to producing prescription medications across several therapeutic areas, including cardiology, oncology, and diabetes. Servier Polska plays a crucial role in providing essential medications to healthcare professionals, patients, and pharmacies, particularly in managing chronic health conditions. The company is part of the Servier Group, which emphasizes research and development, investing significantly in innovative treatments. Servier Polska is committed to maintaining high standards of quality and safety in its manufacturing processes, ensuring that its cardiovascular products meet rigorous international standards. Their focus on cardiology is evident in their product offerings, which include a variety of cardiovascular medications designed to address various heart-related conditions.

23. Laboratoires Biogalenic

• Website: biogalenicpharma.com
• Ownership type: Private
• Headquarters: Constantine, Constantine, Algeria
• Employee distribution: Algeria 98%, Other 2%
• Founded year: 1999
• Headcount: 201-500
• LinkedIn: laboratoires-biogalenic

Laboratoires Biogalenic, established in 1999, is a private pharmaceutical manufacturer based in Constantine, Algeria. The company specializes in producing a wide array of medications aimed at various health conditions, with a notable emphasis on cardiovascular drugs. Among their offerings are products like Cardaxel BGL, which is used for treating hypertension and heart failure. Biogalenic operates multiple production facilities and employs around 260 individuals, many of whom are highly educated professionals. The company is dedicated to improving patient health through innovative pharmaceutical solutions and maintains a strong commitment to quality control in its manufacturing processes. With a portfolio of over 114 products across 12 therapeutic specialties, Biogalenic plays a significant role in the Algerian pharmaceutical market, particularly in the cardiovascular segment.

24. Macleods Pharmaceuticals LTD.

• Website: macleodspharma.com
• Ownership type: Private
• Headquarters: Mumbai, Maharashtra, India
• Employee distribution: India 98%, Other 2%
• Founded year: 1989
• Headcount: 10001+
• LinkedIn: macleods-pharmaceuticals-ltd.

Macleods Pharmaceuticals LTD., based in Mumbai, Maharashtra, India, is a private pharmaceutical company founded in 1989. With over 10,000 employees, the company focuses on developing, manufacturing, and marketing a wide array of pharmaceutical products. Macleods serves healthcare providers, hospitals, and pharmacies, providing solutions across various therapeutic areas, including anti-infectives, cardiovascular, and anti-diabetic medications. The company operates multiple manufacturing units and has a strong global distribution network, ensuring accessibility to quality medicines. Their commitment to research and development is evident through their bioequivalence centers and comprehensive R&D facilities, which support the development of active pharmaceutical ingredients and formulations. Macleods is recognized as one of the top companies in the Indian pharmaceutical market, emphasizing quality and accessibility in their operations.

25. Arena Life Science

• Website: arenalifescience.com
• Ownership type: Private
• Headquarters: Tehran, Tehran, Iran
• Employee distribution: Iran 100%
• Founded year: 2014
• Headcount: 51-200
• LinkedIn: arena-life-science

Arena Life Science, founded in 2014 and based in Tehran, Iran, is a private pharmaceutical company dedicated to developing and manufacturing a range of medications. The company focuses on critical health conditions, including cardiovascular diseases, diabetes, and rheumatoid arthritis. With a workforce of approximately 73 employees, Arena Life Science has made significant strides in the pharmaceutical sector, particularly in the cardiovascular domain. Their product offerings include notable medications such as Rivaroxaban (Axabin), Apixaban (Apirax), Ticagrelor (Ticalix), and Warfarin (Rifana), which are essential for managing various cardiovascular conditions. Arena Life Science has also been recognized for its commitment to quality and innovation, having received a Science-Based certificate in 2016, distinguishing it among Iranian pharmaceutical companies. The company aims to improve health outcomes through high-quality pharmaceutical products and has established itself as a key player in the Iranian market.

26. Servier UK

• Website: servier.co.uk
• Ownership type: Private
• Headquarters: Stoke Poges, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Founded year: 1964
• Headcount: 51-200
• LinkedIn: servier-uk

Servier UK, established in 1964, is a subsidiary of the international pharmaceutical group Servier, which operates under a non-profit foundation. The company is headquartered in Stoke Poges, England, and employs around 39 people. Servier UK focuses on therapeutic progress across several areas, including oncology, neuroscience, immuno-inflammation, and notably, cardiometabolism. The company is dedicated to addressing cardiovascular diseases, which are a significant global health concern. Servier UK invests heavily in research and development, allocating over 20% of its revenue from brand-name medicines to this purpose. Their product portfolio includes several cardiovascular medications, such as Coversyl Arginine, which is used to treat hypertension and heart failure. This commitment to innovation and patient care positions Servier UK as a relevant player in the cardiovascular drug manufacturing sector.

Cardiovascular Drug Manufacturing Insights: Key Companies

Want to Find More Cardiovascular Drug Manufacturing Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!